IP Verse

Solubility Optimization Of Immunobinders - EP2307455

PATENT ANALYSIS

Patent Details

Grant Date
Mar 22, 2017
Company
ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Oppositions

GREAVES BREWSTER LLP

More patents of Esbatech, An Alcon Biomedical Research Unit Llc

EP2307457

EP2307455

Want to monitor this patent?

Feel free to send us a message here and we will get back to you